EVP R&D, Chief Medical Officer
Thu, Jan 30, 2025
Jan 30
29,156 shares @ $20.03
Increased holdings by +61.30%
Net across this filing: -6.90% (-3,286 shares)
13th largest trade (out of 157)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: -6.9% (-3,286 shares)
Insider trade was 37% below market price
Price 18% above 200-day moving average